Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BBIO · NASDAQ · Pharmaceutical Preparations
$76.03−2.15 (−2.75%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Bridgebio Pharma (BBIO) · oqro.io/stocks/BBIO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 18, 2026 · Filed Nov 20, 2026
CEO sold ~$2.37M of BBIO shares in the open marketSourceInsider trade · Traded Nov 18, 2026 · Filed Nov 20, 2026
CEO sold ~$679K of BBIO shares in the open marketSourceInsider trade · Traded Nov 19, 2026 · Filed Nov 20, 2026
CEO sold ~$666K of BBIO shares in the open marketSourceInsider trade · Traded Nov 18, 2026 · Filed Nov 20, 2026
CEO sold ~$346K of BBIO shares in the open marketSourceInsider trade · Traded Nov 19, 2026 · Filed Nov 20, 2026
CEO sold ~$119K of BBIO shares in the open marketSourceInsider trade · Traded Nov 18, 2026 · Filed Nov 20, 2026
CEO sold ~$98K of BBIO shares in the open marketSourcePlanned sale · Planned for Nov 19, 2026 · Notice filed Nov 19, 2026
Officer filed to sell about $2.34M of BBIO stockSourcePlanned sale · Planned for Nov 18, 2026 · Notice filed Nov 18, 2026
Officer filed to sell about $2.69M of BBIO stockSourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Bridgewater Associates disclosed an increased position in BBIO for Q3 2026SourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Viking Global disclosed a reduced position in BBIO for Q3 2026SourcePolitician trade (House) · Transaction Nov 2, 2026 · Disclosed Nov 10, 2026
Disclosed purchase of BBIO — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Oct 27, 2026 · Disclosed Nov 10, 2026
Disclosed purchase of BBIO — reported range $1,001 - $15,000SourceInsider trade · Traded Oct 30, 2026 · Filed Nov 3, 2026
Officer sold ~$146K of BBIO shares in the open marketSourcePolitician trade (House) · Transaction Sep 29, 2026 · Disclosed Oct 12, 2026
Disclosed partial sale of BBIO — reported range $1,001 - $15,000SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Weiss Asset Management LP disclosed a new position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Longaeva Partners L.P. disclosed a new position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Farallon Capital Management, L.L.C. disclosed an increased position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Frazier Life Sciences Management, L.P. disclosed a reduced position in BBIO for Q2 2026Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 24, 2026
Mizuho Markets Americas LLC disclosed an increased position in BBIO for Q2 2026SourcePolitician trade (House) · Transaction May 11, 2026 · Disclosed Jun 8, 2026
Disclosed purchase of BBIO — reported range $1,001 - $15,000SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Frazier Life Sciences Management, L.P. disclosed a reduced position in BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Viking Global disclosed a reduced position in BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates disclosed an increased position in BBIO for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed May 15, 2026
Farallon Capital Management, L.L.C. disclosed an increased position in BBIO for Q4 2025Politician trade (House) · Transaction Mar 19, 2026 · Disclosed Apr 7, 2026
Disclosed purchase of BBIO — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Mar 18, 2026 · Disclosed Apr 7, 2026
Disclosed purchase of BBIO — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Mar 3, 2026 · Disclosed Apr 7, 2026
Disclosed purchase of BBIO — reported range $1,001 - $15,000SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Viking Global disclosed a reduced position in BBIO for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Feb 17, 2026
Farallon Capital Management, L.L.C. disclosed an increased position in BBIO for Q3 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Frontier Capital Management Co LLC disclosed an increased position in BBIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Polar Capital Holdings Plc disclosed an increased position in BBIO for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in BBIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Hood River Capital Management LLC disclosed a new position in BBIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Polar Capital Holdings Plc disclosed a new position in BBIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Viking Global disclosed a reduced position in BBIO for Q3 2025Politician trade (House) · Transaction Sep 22, 2025 · Disclosed Oct 10, 2025
Disclosed purchase of BBIO — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Aug 8, 2025 · Disclosed Sep 12, 2025
Disclosed purchase of BBIO — reported range $1,001 - $15,000SourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
Director sold ~$3.93M of BBIO shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
CEO sold ~$893K of BBIO shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
CEO sold ~$898K of BBIO shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 22, 2025
CFO sold ~$2.09M of BBIO shares in the open marketSourceInsider trade · Traded Aug 20, 2025 · Filed Aug 22, 2025
CEO sold ~$1.26M of BBIO shares in the open marketSourceInsider trade · Traded Aug 20, 2025 · Filed Aug 22, 2025
CEO sold ~$21K of BBIO shares in the open marketSourceInsider trade · Traded Aug 18, 2025 · Filed Aug 19, 2025
CFO sold ~$771K of BBIO shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bellevue Group AG disclosed an increased position in BBIO for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Aug 14, 2026
Farallon Capital Management, L.L.C. disclosed an increased position in BBIO for Q1 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Driehaus Capital Management LLC no longer reported BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP no longer reported BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Susquehanna Portfolio Strategies, LLC disclosed an increased position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Frontier Capital Management Co LLC disclosed an increased position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates disclosed an increased position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Viking Global disclosed a reduced position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Lord, Abbett & Co. LLC disclosed a reduced position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Gilder Gagnon Howe & Co LLC disclosed an increased position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Hood River Capital Management LLC disclosed an increased position in BBIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Polar Capital Holdings Plc disclosed a reduced position in BBIO for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Paradigm Biocapital Advisors LP no longer reported BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Polar Capital Holdings Plc disclosed an increased position in BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Driehaus Capital Management LLC disclosed a reduced position in BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed an increased position in BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Frontier Capital Management Co LLC disclosed an increased position in BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Eventide Asset Management, LLC disclosed an increased position in BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Gilder Gagnon Howe & Co LLC disclosed a reduced position in BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Lord, Abbett & Co. LLC disclosed an increased position in BBIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Mizuho Markets Americas LLC disclosed an increased position in BBIO for Q1 2026SourcePolitician trade (House) · Transaction Apr 29, 2026 · Disclosed May 8, 2026
Disclosed purchase of BBIO — reported range $1,001 - $15,000SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 4, 2026
Hillsdale Investment Management Inc. disclosed an increased position in BBIO for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Driehaus Capital Management LLC disclosed an increased position in BBIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Bridgewater Associates disclosed a new position in BBIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Frazier Life Sciences Management, L.P. disclosed a reduced position in BBIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed a reduced position in BBIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Eventide Asset Management, LLC disclosed a reduced position in BBIO for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deep Track Capital, LP disclosed an increased position in BBIO for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Nov 14, 2025
Farallon Capital Management, L.L.C. disclosed an increased position in BBIO for Q2 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Eventide Asset Management, LLC disclosed an increased position in BBIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Paradigm Biocapital Advisors LP disclosed a reduced position in BBIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frontier Capital Management Co LLC disclosed an increased position in BBIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Driehaus Capital Management LLC disclosed a reduced position in BBIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 10, 2025
Hillsdale Investment Management Inc. disclosed an increased position in BBIO for Q3 2025SourceInsider trade · Traded Sep 4, 2025 · Filed Sep 8, 2025
CEO sold ~$745K of BBIO shares in the open marketSourceInsider trade · Traded Sep 4, 2025 · Filed Sep 8, 2025
CEO sold ~$743K of BBIO shares in the open marketSourceInsider trade · Traded Sep 4, 2025 · Filed Sep 8, 2025
CEO sold ~$284K of BBIO shares in the open marketSourceInsider trade · Traded Sep 4, 2025 · Filed Sep 8, 2025
CEO sold ~$282K of BBIO shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
CEO sold ~$119K of BBIO shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
CEO sold ~$120K of BBIO shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
CEO sold ~$48K of BBIO shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
CEO sold ~$43K of BBIO shares in the open marketSourceInsider trade · Traded Aug 18, 2025 · Filed Aug 19, 2025
CFO sold ~$101K of BBIO shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 15, 2025
Duquesne Family Office no longer reported BBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Paradigm Biocapital Advisors LP disclosed a new position in BBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Kohlberg Kravis Roberts & Co. L.P. disclosed a reduced position in BBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Viking Global disclosed a reduced position in BBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deep Track Capital, LP disclosed a reduced position in BBIO for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Aug 14, 2025
Farallon Capital Management, L.L.C. disclosed an increased position in BBIO for Q1 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Eventide Asset Management, LLC disclosed a reduced position in BBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Frontier Capital Management Co LLC disclosed a reduced position in BBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Driehaus Capital Management LLC disclosed an increased position in BBIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 12, 2025
Hillsdale Investment Management Inc. disclosed a new position in BBIO for Q2 2025SourceInsider trade · Traded Aug 8, 2025 · Filed Aug 12, 2025
Director sold ~$8.79M of BBIO shares in the open marketSourceInsider trade · Traded Aug 8, 2025 · Filed Aug 12, 2025
Director sold ~$2.72M of BBIO shares in the open marketSource